hydroquinone cream

DRUG3 trials

Sponsors

Callender Center for Clinical Research, DermBiont, Inc., National Skin Centre

Conditions

HyperpigmentationMelanosisMelasma

Phase 2

Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos

CompletedNCT05511948

DermBiont, Inc.Hyperpigmentation

Start: 2022-08-18End: 2023-03-07Updated: 2023-10-25

Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study

CompletedNCT06957834

National Skin CentreMelasma

Start: 2023-06-06End: 2024-07-11Updated: 2025-05-05

Phase 4

Azelaic Acid Versus Hydroquinone in Melasma

Callender Center for Clinical ResearchMelanosis

Start: 2009-06-30End: 2010-12-31Target: 30Updated: 2009-06-25

Related Papers

Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double‐Blinded, Split‐Face–Controlled Pilot Trial

Dermatologic Therapy2026-01-01